54
Participants
Start Date
July 2, 2014
Primary Completion Date
October 27, 2022
Study Completion Date
October 27, 2022
nonacog beta pegol
For intravenous (i.v.) injection. A single dose of 40 U/kg, unless the bleeding episode is severe in which case it should be treated with 80 U/kg.
National Taiwan University Children's Hospital, Taipei
Changhua Christian Hospital, Changhua
Kaohsiung Medical University Chung-Ho Memorial Hospital_Dept of Pediatrics, Kaohsiung City
Royal Children's Hospital, Parkville
LKH Salzburg- Univ. Klinik f. Kinder- und Jugendheilkunde, Salzburg
RAMA-Dept of Paediatrics, Bangkok
Hospital Pulau Pinang_Georgetown, Penang, George Town
St Christopher Hosp for Child, Philadelphia
Hospital Tengku Ampuan Afzan, Kuantan
Hospital Universitario La Paz, Madrid
St.Jude Clin-NovantHemby Child, Charlotte
Vanderbilt Hemostasis Thrombosis Clinic, Nashville
China Medical University Hospital - Children Building, Taichung
Hospital Tengku Ampuan Rahimah, Klang, Selangor
Univ Hosp Cleveland Med Ctr, Cleveland
Hospital La Fe - Endocrinología y Nutrición, Valencia
Maharaj Nakorn Chiang Mai Hospital -Pediatric Hematology and Oncology, Chiang Mai
National Blood Centre, Kuala Lumpur
Sheba MC - The Israeli National Hemophilia Center, Tel Litwinsky
St. Luke's Mountain States Tumor Institute, Boise
Univ of Utah Primary Children's Hospital, Salt Lake City
Children's Hospital Los Angeles - Endocrinology, Los Angeles
Children's Hosp-New Orleans, New Orleans
Univ of NE Med Center_Omaha, Omaha
Universitätsklinik für Kinder- und Jugendheilkunde, Vienna
Hamltn Hth Sci/McMstr Child Hosp, Hamilton
Saitama Children's Med Centre_Hematology-Oncology, Saitama
Hospital Sant Joan de Déu, Esplugues Llobregat
Leicester Royal Infirmary - Haemostasis & Thrombosis Unit, Leicester
St Thomas' Hospital - Haemostasis and Thrombosis Centre, London
John Radcliffe Hospital, Oxford
Lead Sponsor
Novo Nordisk A/S
INDUSTRY